← Back
Data updated: Mar 10, 2026
CHEMI SPA
NeurologyOncology
CHEMI SPA is a generic drug manufacturer focused on Neurology, Oncology. Key products include DECITABINE.
2014
Since
4
Drugs
-
Trials
49
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
GLATIRAMER ACETATE 2026-02-11
GLATIRAMER ACETATE 2026-02-11
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 50%
1 drugs
Oncology 50%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (0)
Company Info
- First Approval
- 2014-09-02
- Latest
- 2025-05-07
- Applications
- 4